Skip to main content
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
9.14
+0.08 (0.88%)
Mar 9, 2026, 2:49 PM EDT - Market open

ARS Pharmaceuticals Revenue

In the year 2025, ARS Pharmaceuticals had annual revenue of $84.28M, down -5.46%. ARS Pharmaceuticals had revenue of $28.09M in the quarter ending December 31, 2025, a decrease of -67.56%.

Revenue (ttm)
$84.28M
Revenue Growth
-5.46%
P/S Ratio
10.61
Revenue / Employee
$504,659
Employees
167
Market Cap
903.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202584.28M-4.87M-5.46%
Dec 31, 202489.15M89.12M297,063.33%
Dec 31, 202330.00K-1.29M-97.72%
Dec 31, 20221.32M-4.19M-76.10%
Dec 31, 20215.51M-12.33M-69.13%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.72B
Arvinas 262.60M
Valneva SE 211.09M
Maravai LifeSciences Holdings 185.74M
Phathom Pharmaceuticals 175.11M
uniQure 16.10M
Arbutus Biopharma 14.61M
Janux Therapeutics 10.00M
Revenue Rankings

SPRY News

More News